Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.

Pagani IS, Krishnan V, Ouyang JF, Kok CH, Chen B, Lee KL, Pham CM, Wang P, Page E, Dang P, Saunders VA, James J, Lim K, Mangiola S, Gao Y, Shanmuganathan N, Yong A, Branford S, Chuah C, Yeung DT, White DL, Helgason VG, Thomas D, Ong ST, Hughes TP, Ross DM

Open source

DOI: 10.1002/hem3.70429
Published: 2026 Sep
Container: HemaSphere
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/hem3.70429,
  title = {Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.},
  author = {Pagani IS and Krishnan V and Ouyang JF and Kok CH and Chen B and Lee KL and Pham CM and Wang P and Page E and Dang P and Saunders VA and James J and Lim K and Mangiola S and Gao Y and Shanmuganathan N and Yong A and Branford S and Chuah C and Yeung DT and White DL and Helgason VG and Thomas D and Ong ST and Hughes TP and Ross DM},
  year = {2026},
  journal = {HemaSphere},
  doi = {10.1002/hem3.70429},
  url = {https://doi.org/10.1002/hem3.70429}
}

RIS

TY  - JOUR
TI  - Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.
AU  - Pagani IS
AU  - Krishnan V
AU  - Ouyang JF
AU  - Kok CH
AU  - Chen B
AU  - Lee KL
AU  - Pham CM
AU  - Wang P
AU  - Page E
AU  - Dang P
AU  - Saunders VA
AU  - James J
AU  - Lim K
AU  - Mangiola S
AU  - Gao Y
AU  - Shanmuganathan N
AU  - Yong A
AU  - Branford S
AU  - Chuah C
AU  - Yeung DT
AU  - White DL
AU  - Helgason VG
AU  - Thomas D
AU  - Ong ST
AU  - Hughes TP
AU  - Ross DM
PY  - 2026
JO  - HemaSphere
DO  - 10.1002/hem3.70429
UR  - https://doi.org/10.1002/hem3.70429
ER  -

APA

IS, P., V, K., JF, O., CH, K., B, C., KL, L., CM, P., P, W., E, P., P, D., VA, S., J, J., K, L., S, M., Y, G., N, S., A, Y., S, B., C, C., DT, Y., DL, W., VG, H., D, T., ST, O., TP, H., & DM, R. (2026). Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.. HemaSphere. https://doi.org/10.1002/hem3.70429

Source records

pubmed · retrieved 2026-09-26T16:22:43.048Z